Mektovi Tablet, Film Coated
Product Images NDC 70255-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mektovi (NDC 70255-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Array Biopharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mektovi 01)

FDA Label Image

Figure 1 (Mektovi 02)

Figure 1 (Mektovi 02)
The available text is a graph representing the probability of progression-free survival for two different drugs against patients with an unknown condition. The drugs compared are MEKTOVI + encorafenib and Vemurafenib. The x-axis represents the number of patients at risk, and the y-axis displays the probability of progression-free survival.*
FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Carton)

FDA Label Image

Mektovi 04

Mektovi 04
Not available. The text appears to be a mix of random letters, numbers, and fragmented words with no coherent meaning or context.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.